Riordan Clinic IVC Academy Teaches Doctors About the Use of High Dose Vitamin C.

Feb 10, 2015, 14:59 ET from Riordan Clinic

SAN JUAN, Puerto Rico, Feb 10, 2015 /PRNewswire-USNewswire/ -- The Riordan Clinic is hosting its 2nd Riordan IVC Academy on March 13th and 14th at La Concha Resort in San Juan, Puerto Rico. The IVC Academy will introduce the concepts of high dose intravenous vitamin C (IVC) as an adjunctive clinical therapy. Medical professionals from around the world will attend the conference and take a collaborative look at the use of IVC therapy as a safe and effective adjunct to conventional approaches.

Thirty years ago, Dr. Hugh Riordan treated his first cancer patient with high doses of intravenous vitamin C. The patient was a 70 year-old gentleman with kidney cancer and metastasis to the liver and lungs. Dr. Riordan offered to treat this cancer patient "palliatively" with 30 grams of ascorbic acid (Vitamin C) intravenously twice a week.  After 15 months of therapy, the cancer was gone. 

Some 70,000 vitamin C infusions later, Dr. Riordan and his research team demonstrated scientific evidence to support the use of high dose ascorbate in the adjunctive care of cancer patients [1]. Studies at the US National Institutes of Health have since replicated and advanced these findings [2].

Interest continues to grow through practitioners from around the world who have adopted the freely accessible "Riordan IVC Protocol" for the administration of high dose IVC for the treatment of cancer, viral infections and other health concerns in a non-toxic fashion.

The Riordan Clinic hopes to continue this bold new initiative by hosting several IVC Academy's across the world over the next couple years.  More information on the Riordan IVC Academy can be found online at:  http://www.IVCacademy.org

For more information about vitamin c research and the Riordan IVC Protocol, visit:

http://riordanclinic.org/research-study/vitamin-c-research-ivc-protocol/

References:

  1. Intravenous Ascorbate as a Tumor Cytotoxic Chemotherapeutic Agent. http://www.ncbi.nlm.nih.gov/pubmed/7609676
  2. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. http://www.ncbi.nlm.nih.gov/pubmed/17502596

About Riordan Clinic

Riordan Clinic is a 501(c)3 not-for profit organization focused on functional and integrative approaches to medicine, clinical laboratory testing, health education and research. Since 1975, people worldwide have turned to Riordan Clinic for individualized, solutions-oriented, medical support. For more information about the Riordan Clinic, visit http://www.RiordanClinic.org

 

SOURCE Riordan Clinic



RELATED LINKS

http://www.riordanclinic.org